Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis

Cysteamine, a drug approved to treat cystinosis, has been proposed as a host-directed therapy for (Mtb) and SARS-CoV-2. The impact of cysteamine on the immune responses has not been fully investigated. We aimed to evaluate the immunomodulatory effects of cysteamine on peripheral blood mononuclear ce...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 15; p. 1411827
Main Authors: Najafi-Fard, Saeid, Farroni, Chiara, Petrone, Linda, Altera, Anna Maria Gerarda, Salmi, Andrea, Vanini, Valentina, Cuzzi, Gilda, Alonzi, Tonino, Nicastri, Emanuele, Gualano, Gina, Palmieri, Fabrizio, Piacentini, Mauro, Goletti, Delia
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media SA 28.10.2024
Frontiers Media S.A
Subjects:
ISSN:1664-3224, 1664-3224
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first